Sale

Immunodiagnostics Market

Global Immunodiagnostics Market Size, Share, Growth, Trends: By Product Type: Reagents and Kits, Consumables, Instruments, Software, Service; By Technology: Chemiluminescence Immunoassay, Radioimmunoassay, Enzyme-Linked Immunosorbent Assay, Others; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Immunodiagnostics Market Size

The global immunodiagnostics market is expected to grow at a CAGR of 6.10% between 2024 and 2032, driven by increasing geriatric population and use of immunodiagnostics in rapid testing across the globe.

 

immunodiagnostics market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Immunodiagnostics Market Outlook

  • Infectious diseases, respiratory infections, HIV, and cancer, among others, have become widely prevalent. Early diagnostics can significantly improve patient outcomes, thereby increasing the demand for the immunodiagnostics and fuelling the market growth.
  • Advancements in the assays, diagnostic kits, modules, and analyzers is expected to impact the market value positively.
  • Beyond clinical uses, additional applications of immunodiagnostics in areas such as forensic science, food analysis, and environmental analysis are expected to be an emerging trend in the market, that would help in examining parasite and pathogen presence.

 

Global Immunodiagnostics Market Overview

Immunodiagnostics is a novel in-vitro diagnostic technique that focuses on the reaction between antigens and antibodies for diagnosing infections and chronic conditions. It involves the application of a variety of methods, including radiological, fluorescent, color-forming enzymes, and probes. This innovative approach facilitates the detection of specific antibodies related to diseases, widening the possibilities of disease analysis and diagnosis. Immunodiagnostics employs various reagents, instruments, and software solutions. Some of the tools used are enzyme linked immunosorbent assay (ELISA), chemiluminescence immunoassays (CLIA), as well as rapid tests including radioimmunoassay (RIA), and rapid testing. Its uses are widespread within numerous branches of medicine, such as oncology, immunology, pulmonology, endocrinology, oncology, forensic psychology, and the analysis of environmental and food samples. Essentially a crucial utility for medical practitioners, immunodiagnostics is widely used in healthcare centers, hospitals, labs, and research and academic institutions, which require precise diagnosis and rapid disease detection.

 

Global Immunodiagnostics Market Growth Drivers

Increasing Prevalence of Chronic and Infectious Diseases

The increase in the number of patients suffering from serious conditions such as cancer, autoimmune disorders, and infections is the primary reason behind the growing demand for immunodiagnostics. Due to these conditions, it has become essential to have accurate diagnosis measures that will not only quickly identify these conditions but also monitor the patients progressively to ensure better results and halt the advancement of the diseases. Serological tests, therefore, act as crucial diagnostic tools in identifying specific markers that are associated with these diseases to enable healthcare practitioners make conclusive diagnoses and subsequent treatment at the right time. Hence, the growing global incidence of diseases points to the centrality of immunodiagnostics in modern medical practice and fosters market growth for immunodiagnostic products.

 

Technological Advancements in Immunoassay Techniques

CLIA and ELISA have spotted tremendous growth in immunodiagnostics research because of the relative enhancements in assay technologies over time. These advances have indeed changed the way in which diagnostic tests are performed and offer high sensitivity, specificity, and effectiveness in detecting diseases. Highly sensitive biomarkers can also be identified by these advanced tools. Therefore, it becomes easier to diagnose diseases at an earlier stage and continuously monitor the stages of the disease. Moreover, computers and the application of the internet in the analytic field have made work more efficient by cutting down on the time it takes to carry out tests. The improved performances and dependability of present-day immunoassay procedures contribute to their increased popularity and development in the immunodiagnostics industry.

 

immunodiagnostics market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Immunodiagnostics Market Trends

Key Trends Impact
Advancements in Biomarker Discovery The market is witnessing increased preference towards advanced techniques like next-generation sequencing (NGS), mass spectrometry, and proteomics. Used in combination with certain sophisticated and selective biomarker analyses and advanced bioinformatics and data analytics, the immunodiagnostics market is experiencing growth.
Expansion in Emerging Markets The immunodiagnostics market is particularly growing in emerging economies due to enhancements in the healthcare sector, high demand for healthcare services, and advancements in point-of-care testing equipment. These are also the key trends that are fuelling market growth through new technology to increase access to diagnostic tests in populous regions.
Growing Focus on Home-Based Diagnostic Solution There has been a demand for portable diagnostic tools that are also accessible for home use. Self-testing kits enable patients to conduct screen tests in their homes, allowing accessibility, affordability, and convenience.
Development of Multiplex Assays Multiplex assays are receiving significant attention in the market, owing to several advantages including the testing of several biomarkers at a time. High-throughput platforms are excellent at improving diagnostic strategies in terms of cost and time used in diagnosing diseases that have multiple routes, markers, or indicators, like infections and tumour diseases.

 

Recent Developments in the Market

  • In April 2023, ALPCO-GeneProof and Thermo Fisher Scientific collaborated to create TaqPath Menu and GeneProof PCR Kits. These products help in the better diagnosis of diseases and reduce some clinical procedures that may be tiresome, making it easier to enhance the patients’ lives, hence boosting the market.
  • In November 2023, Roche’s launched an enhanced version of its qPCR system LightCycler PRO System, displaying improved functionality and a smooth transition from research to diagnostics. It offers customized testing solutions and a vast range of assays, which assist healthcare specialists in managing various issues and furthering market growth and innovation.

 

Global Immunodiagnostics Market Segmentation

Market Breakup by Product Type

  • Reagents and Kits
  • ConsumablesInstruments
  • Software
  • Service

 

Market Breakup by Technology

  • Chemiluminescence Immunoassay
  • Radioimmunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Immunoassay
  • Rapid Test
  • Others

 

Market Breakup by Application

  • Infectious Diseases
  • Drug Monitoring
  • Oncology and Endocrinology
  • Bone and Mineral Diseases
  • Cardiac Biomarkers
  • Autoimmune Diseases
  • Others

 

Market Breakup by End User

  • Hospitals
  • Clinical laboratories
  • Academic and Research Centres
  • Pharmaceutical and Biotechnology Industry
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Immunodiagnostics Market Share

Market Segmentation Based on Product Types Poised for Growth

In terms of market breakup based on product types, the report offers an insight into reagents and kits, consumables, instruments, software, and services. Reagents and consumables dominate the overall market. This is because there has been tremendous development of new reagents over time to cater the increasing demand in immunoassay tests. Consumable items are products that are constantly being used and must be replaced periodically, leading to recurrent demand. In addition, there is a rise in immunodiagnostic tests and the globalization of reagents, especially in chemiluminescence and fluorescence assays, which contributes to market growth. On the other hand, the software, and services subsegment comes out as the most promising one, due to increased applications of digital solutions in immunodiagnostic platforms. This growth trajectory is driven by the need for efficient management of data, an increase in workflow, and the health improvement and care of patients, especially within the healthcare sector.

 

Market Breakup by Applications Set to Drive Market Growth

In market segmentation by type of application, there is a range of segments including infectious diseases, drug monitoring, oncology and endocrinology, bone and mineral diseases, cardiac biomarkers, autoimmune diseases, and others. The oncology domain stands out as the overall fastest-growing segment, as immunodiagnostics has become essential for diverse roles, such as screening, diagnosis, prognosis, and managing responses to cancer treatments. The incorporation of immunodiagnostics into oncological settings suggests a rapidly expanding market for the oncology segment in the forecast period.

 

immunodiagnostics market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Immunodiagnostics Market Analysis by Region

The regional analysis offers an insight on North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Immunodiagnostics in the Asia Pacific are anticipated to have the highest demand, owing to the increased prevalence rate of infectious diseases in the region. Constant efforts to prevent and control the spread of infections has led to introduction of new products on the market. Other factors that are likely to propel market growth include growing emphasis on healthcare expenditure and increased consciousness among patients. North America is expected to hold a significant market share, driven by advanced healthcare infrastructure and healthcare spending.

 

Leading Players in the Global Immunodiagnostics Market

The key features of the market report include strategic initiatives made patent analysis, and strategic initiatives including funding and investment analysis, partnerships, and collaborations analysis by the leading players. The major companies in the market are as follows:

 

Abbott Laboratories

Abbott Laboratories is an American multinational corporation that deals in health care and medical devices. It was founded in 1888 in Illinois, United States. It creates devices that can be useful for individuals to monitor their health conditions as well as their daily habits.

 

ARKRAY, Inc.

ARKRAY Inc., was established in 1960 and is located in Kyoto, Japan. It is a healthcare agency that produces clinical diagnostic equipment that can be used in urine testing, diabetes, and other related diseases. They have manufactured new products, devices, and gadgets that are easy to use and function in a simple manner.

 

DiaSorin S.p.A.

DiaSorin S.p.A., headquartered in Italy specializes in the manufacturing of diagnostic systems for infectious diseases. It was established in 2000 and boasts a wide range of diagnostic reagents, including molecular and immunological diagnostic reagent kits.

 

Johnson & Johnson Services, Inc.

The company was founded in 1886 and has a strong range of immunodiagnostics products. It possesses ID NOWTM, Deep GeneXpert® Systems to detect infectious diseases, tuberculosis,  respiratory tract infections, malaria, and herpes simplex virus. The company also boasts CELLSEARCH® System which targets cancer patients to identify circulating tumor cells.

 

Other companies in the market include Biotest AG, Immunodiagnostic Systems Holdings plc, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., PerkinElmer Inc., and Shenzhen Mindray Bio-Medical Electronics Co Ltd.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technology 
  • Application
  • End User
  • Region
Breakup by Product Type
  • Reagents and Kits
  • Consumables
  • Instruments
  • Software
  • Service
Breakup by Technology 
  • Chemiluminescence Immunoassay
  • Radioimmunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Immunoassay
  • Rapid Test
  • Others
Breakup by Application
  • Infectious Diseases
  • Drug Monitoring
  • Oncology and Endocrinology
  • Bone and Mineral Diseases
  • Cardiac Biomarkers
  • Autoimmune Diseases
  • Others
Breakup by End User
  • Hospitals
  • Clinical laboratories
  • Academic and Research Centres
  • Pharmaceutical and Biotechnology Industry
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott Laboratories 
  • ARKRAY, Inc
  • DiaSorin S.p.A.
  • Johnson & Johnson Services, Inc. 
  • Biotest AG
  • Immunodiagnostic Systems Holdings plc 
  • F. Hoffmann-La Roche Ltd 
  • Siemens AG 
  • Sysmex Corporation 
  • Danaher Corporation 
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd.

 

Key Questions Answered in the Global Immunodiagnostics Market

  • What was the global immunodiagnostics market value in 2023?
  • What is the global immunodiagnostics market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What are the major factors aiding the global immunodiagnostics market demand? 
  • What are the market's major drivers, opportunities, and restraints? 
  • What is the market segmentation based on product types?
  • What is the market breakup based on technology?
  • What are the application areas of immunodiagnostics?
  • What are the end users of the market?
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to witness expedited growth during the forecast period? 
  • What are the major global immunodiagnostics market trends?
  • How does the rise in the geriatric population impact the market size?
  • Who are the key players involved in the immunodiagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
  • What are the latest advancements in reagents and kits within the immunodiagnostics market?
  • What are the specific needs and preferences of hospitals regarding immunodiagnostic technologies and services?

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2     Executive Summary
3    Global Immunodiagnostics Market Overview 

    3.1    Global Immunodiagnostics Market Historical Value (2017-2023) 
    3.2    Global Immunodiagnostics Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Immunodiagnostics Market Landscape*
    5.1    Global Immunodiagnostics: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Immunodiagnostics: Product Landscape 
        5.2.1    Analysis by Product Type
        5.2.2    Analysis by Application
6    Global Immunodiagnostics Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis 
        6.3.1    Political 
        6.3.2    Economic 
        6.3.3    Social 
        6.3.4    Technological 
        6.3.5    Legal 
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Immunodiagnostics Market Segmentation (2017-2032)
    7.1    Global Immunodiagnostics Market (2017-2032) by Product Type
        7.1.1    Market Overview
        7.1.2    Reagents and Kits
        7.1.3    Consumables
        7.1.4    Instruments
        7.1.5    Software
        7.1.6    Service
    7.2    Global Immunodiagnostics Market (2017-2032) by Technology 
        7.2.1    Market Overview
        7.2.2    Chemiluminescence Immunoassay
        7.2.3    Radioimmunoassay
        7.2.4    Enzyme-Linked Immunosorbent Assay
        7.2.5    Fluorescent Immunoassay
        7.2.6    Rapid Test
        7.2.7    Others 
    7.3    Global Immunodiagnostics Market (2017-2032) by Application
        7.3.1    Market Overview
        7.3.2    Infectious Diseases
        7.3.3    Drug Monitoring
        7.3.4    Oncology and Endocrinology
        7.3.5    Bone and Mineral Diseases
        7.3.6    Cardiac Biomarkers
        7.3.7    Autoimmune Diseases
        7.3.8    Others
    7.4    Global Immunodiagnostics Market (2017-2032) by End User
        7.4.1  Market Overview        
        7.4.2    Hospitals
        7.4.3    Clinical laboratories
        7.4.4    Academic and Research Centres
        7.4.5    Pharmaceutical and Biotechnology Industry
        7.4.6    Others
    7.5    Global Immunodiagnostics Market (2017-2032) by Region
        7.5.1    Market Overview
        7.5.2    North America 
        7.5.3    Europe
        7.5.4    Asia Pacific
        7.5.5    Latin America
        7.5.6    Middle East and Africa
8    North America Immunodiagnostics Market (2017-2032)
    8.1    North America Immunodiagnostics Market (2017-2032) by Product Type
        8.1.1    Market Overview
        8.1.2    Reagents and Kits
        8.1.3    Consumables
        8.1.4    Instruments
        8.1.5    Software
        8.1.6    Service
    8.2    North America Immunodiagnostics Market (2017-2032) by Technology 
        8.2.1    Market Overview
        8.2.2    Chemiluminescence Immunoassay
        8.2.3    Radioimmunoassay
        8.2.4    Enzyme-Linked Immunosorbent Assay
        8.2.5    Fluorescent Immunoassay
        8.2.6    Rapid Test
        8.2.7    Others 
    8.3    North America Immunodiagnostics Market (2017-2032) by Application
        8.3.1    Market Overview
        8.3.2    Infectious Diseases
        8.3.3    Drug Monitoring
        8.3.4    Oncology and Endocrinology
        8.3.5    Bone and Mineral Diseases
        8.3.6    Cardiac Biomarkers
        8.3.7    Autoimmune Diseases
        8.3.8    Others
    8.4    North America Immunodiagnostics Market (2017-2032) by End User
        8.4.1    Hospitals
        8.4.2    Clinical laboratories
        8.4.3    Academic and Research Centres
        8.4.4    Pharmaceutical and Biotechnology Industry
        8.4.5    Others
    8.5    North America Immunodiagnostics Market (2017-2032) by Country
        8.5.1    United States of America
        8.5.2    Canada
9    Europe Immunodiagnostics Market (2017-2032)
    9.1    Europe Immunodiagnostics Market (2017-2032) by Product Type
        9.1.1    Market Overview
        9.1.2    Reagents and Kits
        9.1.3    Consumables
        9.1.4    Instruments
        9.1.5    Software
        9.1.6    Service
    9.2    Europe Immunodiagnostics Market (2017-2032) by Technology 
        9.2.1    Market Overview
        9.2.2    Chemiluminescence Immunoassay
        9.2.3    Radioimmunoassay
        9.2.4    Enzyme-Linked Immunosorbent Assay
        9.2.5    Fluorescent Immunoassay
        9.2.6    Rapid Test
        9.2.7    Others 
    9.3    Europe Immunodiagnostics Market (2017-2032) by Application
        9.3.1    Market Overview
        9.3.2    Infectious Diseases
        9.3.3    Drug Monitoring
        9.3.4    Oncology and Endocrinology
        9.3.5    Bone and Mineral Diseases
        9.3.6    Cardiac Biomarkers
        9.3.7    Autoimmune Diseases
        9.3.8    Others
    9.4    Europe Immunodiagnostics Market (2017-2032) by End User
        9.4.1    Hospitals
        9.4.2    Clinical laboratories
        9.4.3    Academic and Research Centres
        9.4.4    Pharmaceutical and Biotechnology Industry
        9.4.5    Others
    9.5    Europe Immunodiagnostics Market (2017-2032) by Country
        9.5.1    United Kingdom
        9.5.2    Germany
        9.5.3    France
        9.5.4    Italy
        9.5.5    Others
10    Asia Pacific Immunodiagnostics Market (2017-2032)
    10.1    Asia Pacific Immunodiagnostics Market (2017-2032) by Product Type
        10.1.1    Market Overview
        10.1.2    Reagents and Kits
        10.1.3    Consumables
        10.1.4    Instruments
        10.1.5    Software
        10.1.6    Service
    10.2    Asia Pacific Immunodiagnostics Market (2017-2032) by Technology 
        10.2.1    Market Overview
        10.2.2    Chemiluminescence Immunoassay
        10.2.3    Radioimmunoassay
        10.2.4    Enzyme-Linked Immunosorbent Assay
        10.2.5    Fluorescent Immunoassay
        10.2.6    Rapid Test
        10.2.7    Others 
    10.3    Asia Pacific Immunodiagnostics Market (2017-2032) by Application
        10.3.1    Market Overview
        10.3.2    Infectious Diseases
        10.3.3    Drug Monitoring
        10.3.4    Oncology and Endocrinology
        10.3.5    Bone and Mineral Diseases
        10.3.6    Cardiac Biomarkers
        10.3.7    Autoimmune Diseases
        10.3.8    Others
    10.4    Asia Pacific Immunodiagnostics Market (2017-2032) by End User
        10.4.1    Hospitals
        10.4.2    Clinical laboratories
        10.4.3    Academic and Research Centres
        10.4.4    Pharmaceutical and Biotechnology Industry
        10.4.5    Others
    10.5    Asia Pacific Immunodiagnostics Market (2017-2032) by Country
        10.5.1    China
        10.5.2    Japan
        10.5.3    India
        10.5.4    ASEAN
        10.5.5    Australia
        10.5.6    Others
11    Latin America Immunodiagnostics Market (2017-2032)
    11.1    Latin America Immunodiagnostics Market (2017-2032) by Product Type
        11.1.1    Market Overview
        11.1.2    Reagents and Kits
        11.1.3    Consumables
        11.1.4    Instruments
        11.1.5    Software
        11.1.6    Service
    11.2    Latin America Immunodiagnostics Market (2017-2032) by Technology 
        11.2.1    Market Overview
        11.2.2    Chemiluminescence Immunoassay
        11.2.3    Radioimmunoassay
        11.2.4    Enzyme-Linked Immunosorbent Assay
        11.2.5    Fluorescent Immunoassay
        11.2.6    Rapid Test
        11.2.7    Others 
    11.3    Latin America Immunodiagnostics Market (2017-2032) by Application
        11.3.1    Market Overview
        11.3.2    Infectious Diseases
        11.3.3    Drug Monitoring
        11.3.4    Oncology and Endocrinology
        11.3.5    Bone and Mineral Diseases
        11.3.6    Cardiac Biomarkers
        11.3.7    Autoimmune Diseases
        11.3.8    Others
    11.4    Latin America Immunodiagnostics Market (2017-2032) by End User
        11.4.1    Hospitals
        11.4.2    Clinical laboratories
        11.4.3    Academic and Research Centres
        11.4.4    Pharmaceutical and Biotechnology Industry
        11.4.5    Others
    11.5    Latin America Immunodiagnostics Market (2017-2032) by Country
        11.5.1    Brazil
        11.5.2    Argentina
        11.5.3    Mexico
        11.5.4    Others
12    Middle East and Africa Immunodiagnostics Market (2017-2032)
    12.1    Middle East and Africa Immunodiagnostics Market (2017-2032) by Product Type
        12.1.1    Market Overview
        12.1.2    Reagents and Kits
        12.1.3    Consumables
        12.1.4    Instruments
        12.1.5    Software
        12.1.6    Service
    12.2    Middle East and Africa Immunodiagnostics Market (2017-2032) by Technology 
        12.2.1    Market Overview
        12.2.2    Chemiluminescence Immunoassay
        12.2.3    Radioimmunoassay
        12.2.4    Enzyme-Linked Immunosorbent Assay
        12.2.5    Fluorescent Immunoassay
        12.2.6    Rapid Test
        12.2.7    Others 
    12.3    Middle East and Africa Immunodiagnostics Market (2017-2032) by Application
        12.3.1    Market Overview
        12.3.2    Infectious Diseases
        12.3.3    Drug Monitoring
        12.3.4    Oncology and Endocrinology
        12.3.5    Bone and Mineral Diseases
        12.3.6    Cardiac Biomarkers
        12.3.7    Autoimmune Diseases
        12.3.8    Others
    12.4    Middle East and Africa Immunodiagnostics Market (2017-2032) by End User
        12.4.1    Hospitals
        12.4.2    Clinical laboratories
        12.4.3    Academic and Research Centres
        12.4.4    Pharmaceutical and Biotechnology Industry
        12.4.5    Others
    12.5     Middle East and Africa Immunodiagnostics Market (2017-2032) by Country
        12.5.1    Saudi Arabia
        12.5.2    United Arab Emirates
        12.5.3    Nigeria
        12.5.4    South Africa
        12.5.5    Others
13    Regulatory  Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Strategic Initiative
    15.1     Analysis by Partnership Instances
    15.2     Analysis by Type of Partnership
    15.3     Analysis by Leading Players
    15.4     Analysis by Geography
16    Supplier Landscape
    16.1    Market Share Analysis, By Region (Top 5 Companies)
        16.1.1    Market Share Analysis: Global
        16.1.2    Market Share Analysis: North America
        16.1.3    Market Share Analysis: Europe
        16.1.4    Market Share Analysis: Asia-Pacific
        16.1.5    Market Share Analysis: Others
    16.2    Abbott Laboratories  
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisitions
        16.2.5    Certifications 
    16.3    ARKRAY, Inc . 
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisitions
        16.3.5    Certifications
    16.4    DiaSorin S.p.A .
        16.4.1    Financial Analysis
        16.4.2    Product Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisitions
        16.4.5    Certifications
    16.5    Johnson & Johnson Services, Inc .
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisitions
        16.5.5    Certifications
    16.6    Biotest AG 
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisitions
        16.6.5    Certifications
    16.7    Immunodiagnostic Systems Holdings plc 
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisitions
        16.7.5    Certifications
    16.8    F. Hoffmann-La Roche Ltd 
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisitions
        16.8.5    Certifications
    16.9    Siemens AG 
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisitions
        16.9.5    Certifications 
    16.10    Sysmex Corporation 
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisitions
        16.10.5    Certifications 
    16.11    Danaher Corporation 
        16.11.1    Financial Analysis
        16.11.2    Product Portfolio
        16.11.3    Demographic Reach and Achievements
        16.11.4    Mergers and Acquisitions
        16.11.5    Certifications
    16.12    Thermo Fisher Scientific Inc .
        16.12.1    Financial Analysis
        16.12.2    Product Portfolio
        16.12.3    Demographic
        16.12.4    Mergers and Acquisitions
        16.12.5    Certifications
    16.13    Bio-Rad Laboratories, Inc . 
        16.13.1    Financial Analysis
        16.13.2    Product Portfolio
        16.13.3    Demographic Reach and Achievements
        16.13.4    Mergers and Acquisitions
        16.13.5    Certifications
    16.14    PerkinElmer Inc . 
        16.14.1    Financial Analysis
        16.14.2    Product Portfolio
        16.14.3    Demographic Reach and Achievements
        16.14.4    Mergers and Acquisitions
        16.14.5    Certifications
    16.15    Shenzhen Mindray Bio-Medical Electronics Co Ltd .
        16.15.1    Financial Analysis
        16.15.2    Product Portfolio
        16.15.3    Demographic Reach and Achievements
        16.15.4    Mergers and Acquisitions
        16.15.5    Certifications 
17    Immunodiagnostics  Market – Distribution Model (Additional Insight)
    17.1     Overview 
    17.2     Potential Distributors 
    17.3     Key Parameters for Distribution Partner Assessment 
18    Key Opinion Leaders (KOL) Insights (Additional Insight)

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

 

**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER